Efficacy and safety of glecaprevir and pibrentasvir in Japanese patients with hepatitis C virus infection aged 75 years or older

被引：0
作者：
Yuri Komaki
Yoshinori Ozono
Kenichi Nakamura
Hisayoshi Iwakiri
Satoru Hasuike
Mitsue Sueta
Tadashi Miike
Shojiro Yamamoto
Hirofumi Uto
Kazunori Kusumoto
Toshimasa Ochiai
Junya Kato
Naoto Komada
Kazuo Kuroki
Toshiharu Eto
Masafumi Shigehira
Shuichi Hirono
Kenji Nagata
Hiroshi Kawakami
机构：
[1] University of Miyazaki,Division of Gastroenterology and Hepatology, Department of Internal Medicine, Faculty of Medicine
[2] Miyazaki Medical Center Hospital,Department of Gastroenterology
[3] Koga General Hospital,Department of Internal Medicine
[4] National Hospital Organization Miyakonojo Medical Center,Department of Internal Medicine
[5] Kushima Municipal Hospital,Department of Internal Medicine
[6] Shigehira Clinic,Department of Internal Medicine
[7] Hirono Naika Clinic,Department of Internal Medicine
来源：
BMC Gastroenterology | / 22卷
关键词：
Chronic hepatitis C; Direct-acting antivirals; Glecaprevir; Pibrentasvir; Sustained virological response;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 210 条
[1]  
Lauer GM(2001)Hepatitis C virus infection N Engl J Med 345 41-52
[2]  
Walker BD(2016)Hepatitis C-A clinical review J Med Virol 88 1844-1855
[3]  
Wang LS(2015)A review of the burden of hepatitis C virus infection in China, Japan, South Korea and Taiwan Hepatol Int 9 378-390
[4]  
D’Souza LS(2011)Total numbers of undiagnosed carriers of hepatitis C and B viruses in Japan estimated by age- and area-specific prevalence on the national scale Intervirology 54 185-195
[5]  
Jacobson IM(2012)Disadvantages of peginterferon and ribavirin treatment in older patients with chronic hepatitis C: an analysis using the propensity score Hepatol Int 6 744-752
[6]  
Benett H(2015)Efficacy and safety of interferon treatment in elderly patients with chronic hepatitis C in Japan: a retrospective study using the Japanese Interferon database Hepatol Res 45 829-836
[7]  
Waser N(2017)Clinical evaluation of sofosbuvir/ledipasvir in patients with chronic hepatitis C genotype 1 with and without prior daclatasvir/asunaprevir therapy Hepatol Res 47 1308-1316
[8]  
Johnston K(2019)Efficacy and safety of elbasvir plus grazoprevir combination therapy in Japanese patients infected with hepatitis C virus genotype 1b Hepatol Res 49 256-263
[9]  
Kao JH(2016)Safety and efficacy of ledipasvir/sofosbuvir for the treatment of genotype 1 hepatitis C in subjects aged 65 years or older Hepatology 63 1112-1119
[10]  
Lim YS(2017)Effectiveness and safety of community-based treatment with sofosbuvir plus ribavirin for elderly patients with genotype 2 chronic hepatitis C Dig Liver Dis 49 1029-1035
12345678910